James L. Kirkland

Publishes on Telomeres, Telomerase, and Senescence, Adipokines, Inflammation, and Metabolic Diseases, Genetics, Aging, and Longevity in Model Organisms. 496 papers and 61.3k citations.

PubIndex Score98Top 2%How it's scored

🌟#8 Current Senior Leader in Telomeres, Telomerase, and Senescence 🌟#10 Current Senior Leader in Aging, Health, and Disability

496Publications

61.3kTotal Citations

#8in Telomeres, Telomerase, and Senescence

First publication: 1983First senior author: 1983

Telomeres, Telomerase, and Senescence Adipokines, Inflammation, and Metabolic Diseases Genetics, Aging, and Longevity in Model Organisms Adipose Tissue and Metabolism Glioma Diagnosis and Treatment

Top publicationsby citations

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

Yi Zhu, James L. Kirkland|Aging Cell|2015

Cited by 2.4k

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

Jamie N. Justice, James L. Kirkland, Anoop M. Nambiar et al.|EBioMedicine|2019

Cited by 1.2k

Cellular senescence and senolytics: the path to the clinic

Selim Chaib, James L. Kirkland|Nature Medicine|2022

Cited by 1k

New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463

Yi Zhu, James L. Kirkland|Aging|2017

Cited by 714

Targeting senescent cells alleviates obesity‐induced metabolic dysfunction

Allyson K. Palmer, James L. Kirkland|Aging Cell|2019

Cited by 661